SPCX
Space Exploration Technologies Corp
$123.62-9.05%
Setup
No setup
Buy Zone
$123-$129.15
Sector
Aerospace & Defense
Industry
Aerospace & Defense
72
Recommendation
No setup
Hold
No active chart path confirmed. Keep on watchlist until price, volume, and setup align.
SPCX chart
Loading chart…
Overall Quality72
RS Rating
50
relative strength
Fundamentals
84
Strong fund-Q
Volume Demand
68
+67% vs avg
Technical Setup
25
2/8 checks
Industry/Theme
91
Aerospace & Defense
Trade Plan
No setup
Entry
$123
Entry Zone
$123-$129.15
Stop / Risk
$113.16
RS Rating
50
Volume confirmed
No
Targets
$147.6 / $153.75
Breakout · IBD Setup
1 ✓ 7 ✗
Entry $123–$129.15Stop $113.16Target $147.6 / $153.75
Market regimeRange
Quality72
RS Rating50
Above 50-MA-17.21%
Above 200-MA-14.85%
VolumeWeak
In Buy ZoneNo
Not extendedOK
Invalidation · Close below stop
How this came together
72
MarketRange
SetupNo setup
ConfidenceExperimental · not backtested
Fund-Q84 · Strong
StatusHold
Stock Data
52-Week Range105 – 226
Price % Chg YTD-17.59%
Price % Chg 4wk-26.24%
50-Day Avg Vol102.9 Mil
P/E Ratio—
Market Cap$1.83T
SectorIndustrials
IndustryAerospace & Defense
Company Fundamentals
EPS % Chg (Qtr)523.92%
Sales % Chg (Qtr)258.02%
EPS Growth 5y—
Sales Growth 5y—
Annual ROE—
Gross Margin—
Operating Margin—
Net Margin—
Debt / Equity0.22
Setup levels
Current price
$123.62
Pivot
$123
Distance to buy
-45.2%
52-week range
104.83-225.63
Trigger evidence
No active trigger evidence available.
Financial health checks
3/3
EPS growing quarter on quarter
EPS q/q 523.92%
Sales growing quarter on quarter
Sales q/q 258.02%
Debt to equity below 1.0
D/E 0.22
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE—
Net margin—
Gross margin—
EPS growth q/q523.92%
vs sector +478.0%
Sales growth q/q258.02%
vs sector +231.1%
Debt / equity0.22
vs sector -1.12
Business quality
84
GradeStrong
EPS rating93
P/E—
Market cap$1.83T
IndustryAerospace & Defense
Technical checks
Über 50-MA
Fail
Über 200-MA
Fail
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Fail
In Kaufzone
Fail
Nicht überextended
Pass
Über 21-EMA
Fail
Volumen gesund
Pass
IBD / source mentions
No recent IBD mention found for this ticker.
Signal history
Added to list
2026-11-04
Trigger date
—
Days on list
2
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.